Page last updated: 2024-11-05

tyrphostin a9 and Hodgkin Disease

tyrphostin a9 has been researched along with Hodgkin Disease in 1 studies

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research Excerpts

ExcerptRelevanceReference
"Classical Hodgkin lymphoma (cHL) is a distinct malignancy of the immune system."1.33STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis. ( Holtick, U; Horn, F; Kube, D; Kussebi, N; Lauber, K; Löffler, D; Pinkert, D; Schoof, N; Stürzenhofecker, B; Trümper, L; Vockerodt, M; Wesselborg, S, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holtick, U1
Vockerodt, M1
Pinkert, D1
Schoof, N1
Stürzenhofecker, B1
Kussebi, N1
Lauber, K1
Wesselborg, S1
Löffler, D1
Horn, F1
Trümper, L1
Kube, D1

Other Studies

1 other study available for tyrphostin a9 and Hodgkin Disease

ArticleYear
STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.
    Leukemia, 2005, Volume: 19, Issue:6

    Topics: Apoptosis; Cell Division; DNA-Binding Proteins; Enzyme Inhibitors; fas Receptor; Gene Expression; Ho

2005